Ready before the investigator arrives
By the time an investigator is in your lobby, the outcome is mostly decided. It was decided by whether your records could be found, whether your people could explain the why and not just the what, and whether someone had already walked the site the way an inspector would. Inspection readiness is the discipline of building that state and holding it, so an inspection becomes a demonstration of control rather than a discovery of gaps. We build it, rehearse it, and stand in the room with you when it counts.
A live inspection runs on a front room / back room model. The front room is what the investigator sees. The back room is where it's actually won, anticipating the next request before it's made.
Controlled, calm, and deliberate. Nothing enters this room that hasn't been reviewed, and no one answers more than the question they were asked.
The command center. It reads the pattern in what's being asked and stages the response before the front room needs it.
Readiness isn't a single event. We work across all three phases, or step in wherever the inspection clock has already put you.
Whether you have one inspection on the calendar or a site that must stay inspection-ready year round, we scope to where you are.
Full PAI simulations led by former FDA investigators, run against your actual submission and site, with findings graded the way the agency grades them.
Surveillance and for-cause simulations across drug, biologic, and device operations, testing the quality system the way a real investigator would probe it.
A structured read of documentation, data integrity, facilities, and personnel against inspection expectations, with findings ranked by how an investigator would weight them.
Response strategy and drafting under the 15-day clock: containment, root cause, systemic impact, and a CAPA plan a reviewer will find credible.
Ownership of the corrective program after a difficult inspection: workstreams, evidence, and effectiveness proof, driven to documented closure.
Quarterly assessment cycles, refreshed playbooks, and ongoing SME training that keep a site inspection-ready between inspections, not just before one.
We don't publish vanity metrics. We run to standards, and we put them in writing at the start of every engagement.
A mock finding we call minor when the FDA would call it a 483 observation is worse than useless. We score against the standard the investigator will actually apply.
A playbook nobody has run is a theory. We rehearse the room, the roles, and the document flow until the response is muscle memory, not a binder.
Most observations are handed to the investigator, not found by them. We train SMEs to answer precisely, explain the reasoning, and stop.
The site that passes is the one that was ready last quarter too. We build the cadence that holds the state, so the next inspection isn't a scramble.
Our inspection readiness leads include former FDA investigators and quality heads who have run inspections from both sides. You aren't being staffed with junior consultants under a partner's name; you get the senior practitioner on every call.
Practitioners who have conducted inspections and written the observations, and who know what actually draws an investigator's attention on site.
The lead consultant on your engagement is the one doing the work. We don't bait-and-switch with junior staff after the contract is signed.
We don't just prepare you and leave. Our leads run the back room and coach the front room during the live inspection itself.
FDA, EMA, MHRA, and notified body inspections handled with the regional expectations understood before the investigator raises them.
Tell us what's coming, or what already happened. We'll match you with a senior inspection readiness lead and respond within one business day. All inquiries are strictly confidential.